0% found this document useful (0 votes)
19 views7 pages

UNODC - (Peru) IIT - TWMUN

Uploaded by

iamkyros
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
19 views7 pages

UNODC - (Peru) IIT - TWMUN

Uploaded by

iamkyros
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 7

Agenda - Combating Corruption in the Healthcare Sector

Hydra Heads

Bidding Rigging: Inflating prices, killing competition: Corrupt contractors collaborate to drain
the resources of healthcare systems. Looking at high-profile cases, such as the oxygen
procurement scandal of 2020.

Kickbacks and Bribery: Suppliers bribe decision-makers to win costly contracts in exchange for
sub-standard quality. Probe into the incidence of bribes in procurement.

Counterfeiting: Fake or inferior drugs get into circulation, jeopardizing patients' lives and
undermining public confidence in health care.

Illegal Diversion: Medicines deemed essential for hospitals also filter into private clinics and
onto the black market, leaving many vulnerable to illness: research diversion routes, and
enforcement efforts.

Price Manipulation: Artificial monopolies by drug companies or collusive agreements inflate


prices, massively increasing healthcare costs not only for people but also for the government.

Government: Presidential Republic


Capital: Lima
Official Language: Spanish
Population: 32 million
GSL

Respected Chair, distinguished delegates,

Our common enemy—corruption in the healthcare sector—is what unites us, not national
boundaries. Millions of people are put in danger as a result of this hydra, which depletes life-
saving resources worldwide.

Pharmaceutical monopolies, doctor bribes, and manipulated procurement poison this crucial
industry. The depths of this unfairness are revealed by UN investigations and whistleblowing
hotlines, as health becomes a luxury rather than an aspect of aid.

There is a glimmer of optimism even in the depths of the night. For communities that seek
accountability, civil society organizations and UN agencies serve as beacons of hope. Their light
directs us toward a healthcare system that benefits everyone, not just the wealthy.

Fighting for a future where everyone has the right to good health is more important than simply
money. Let's pool our resources, knowledge, and political power under this flag. Let's make
healthcare at no cost accessible to all people on Earth.

We can defeat this hydra together. Health for all is a necessity, not a luxury. Let's construct it
together.

Thank You
MOD Speech - Discussing measures to increase surveillance in hospitals and government
offices to prevent corruption

Esteemed Chair, distinguished delegates,


Corruption permeates the healthcare industry. It robs life-saving resources and taints religion.
We cannot remain spectators.

Think of a British hospital, where hidden cameras discourage bribes before they start. A Danish
procurement office, where every bid is recorded and open to the public. The kryptonite to
corruption and its watchful eye is transparency through surveillance. Privacy is important.
However, these actions must be supported by security measures, data protection, and
whistleblower protection.

Even government offices must have transparency. As in the case of Brazil's public budget
system, open access to contracts and spending gives citizens a way to evaluate their officials.
Like Chile's highly respected anti-corruption agency, it takes outside views into account in the
policy-making process as well.

But more than technology is needed. To foster an honest society where they can thrive, it is
equally essential that we instruct officials and healthcare personnel in ethics.

Finally, cooperation is needed. Let's form a global anti-corruption coalition, exchanging


experience and data. Justice isn't something that borders can stop.

This is a fight where surveillance plays an important role, every resource heals, not harms. Every
life is valued in this healthcare system we build together.

Thank you.
Country Challenges Initiatives
Bribery, ghost patients, nepotism, procurement e-Health systems, stronger anti-corruption agencies,
Albania irregularities whistleblower protection, public awareness
Fraudulent billing, overservicing, pharmaceutical Strong legal framework, oversight bodies, data analy
Australia kickbacks transparency for pharmaceutical companies
Bribery for referrals, drug abuse, fraudulent home Strict anti-corruption laws, public reporting platform
Belgium care claims collaboration with healthcare professions

Widespread bribery, ghost workers, poor Public healthcare infrastructure investment, stronger
Bolivia procurement practices auditing, community monitoring of hospitals

Bureaucracy facilitating bribery, misallocated funds, Anti-corruption task forces, digital reporting platform
Brazil fake prescriptions stricter pharmaceutical regulations

Bribery for preferential treatment, nepotistic Independent anti-corruption commission, increased


Bulgaria appointments, illegal drug trade procurement transparency, healthcare worker educat

Limited access due to corruption, embezzlement, Decentralized healthcare services, community monit
Burkina Faso resource allocation opacity anti-corruption awareness campaigns

Bribery for specialists, pharmaceutical rebates, Anti-corruption reforms, digital payments, stronger
China medication overprescription medical institution oversight

Fraudulent social security claims, drug procurement Strong legal framework, independent ombudsman sy
Costa Rica influence peddling, official abuse of power proactive public participation
Strengthened procurement oversight, whistleblower
Bribery for procedures/appointments, pharmaceutical protection mechanisms, healthcare decision-making
Croatia contract conflicts of interest, nepotistic hiring transparency

Bribery for faster treatment, nepotism in hiring, ghost Electronic appointment systems, stronger whistleblo
Cyprus workers in hospitals protection, public awareness campaigns
Decentralized healthcare governance, community-ba
Lack of transparency in resource allocation, bribery anti-corruption committees, improved financial
DR of Congo for medication access, embezzlement of funds management systems
Bribery for medical services, influence peddling in
pharmaceuticals, lack of accountability in public Independent anti-corruption commission, improved
Ecuador hospitals collection and analysis, public reporting platforms
Fraudulent billing for unnecessary procedures, Strong ethical guidelines for healthcare professional
nepotism in medical appointments, conflicts of transparent public procurement processes, independe
Finland interest in research funding oversight bodies
Bribery for specialized care, kickbacks from Anti-corruption legislation specifically targeting
pharmaceutical companies, overprescription of healthcare, whistleblower protection programs, incre
France antibiotics transparency in drug pricing
Bribery for faster surgery dates, conflicts of interest Independent anti-corruption agency, mandatory ethic
in medical device procurement, ghost patients in training for healthcare professionals, public awarene
Germany specialist clinics campaigns
Bribery for basic healthcare services, misallocation Decentralized healthcare systems, community-based
of public funds, poor quality medicines due to monitoring mechanisms, increased use of technology
Ghana corruption transparency
Bribery for shorter wait times, nepotism in hiring Electronic medical records systems, independent
healthcare staff, fraudulent claims for medical healthcare inspectorate, public access to hospital
Greece supplies performance data
Stricter regulations for pharmaceutical companies,
Bribery for specialized drugs, conflicts of interest in increased transparency in healthcare budgets, strong
Hungary hospital management, overbilling for procedures whistleblower protection

Bribery for admission to public hospitals, fake


prescriptions for unnecessary medication, poor Digital health initiatives, anti-corruption task forces,
India quality medicines due to corruption increased public awareness and community involvem
Bribery for high-tech treatments, opaque Public awareness campaigns, strengthened conflict o
pharmaceutical pricing, nepotism in medical school interest regulations, independent price evaluation
Japan admissions mechanisms
Bribery for access to specialist care, overprescribing Public-private partnerships to improve healthcare
of medication, fake prescriptions for unauthorized infrastructure, stronger pharmaceutical regulations,
Morocco drugs community monitoring of pharmacies
Fraudulent billing for unnecessary procedures, Independent healthcare inspectorate, mandatory
conflicts of interest in research funding, bribery for transparency reports for pharmaceutical companies,
Netherlands faster appointments whistleblower protection
Bribery for elective surgeries, influence peddling in Robust anti-corruption legislation, independent publ
medical equipment procurement, nepotism in procurement agency, data-driven monitoring of heal
New Zealand healthcare appointments spending
Bribery for basic medical services, lack of Community health insurance schemes, independent
transparency in resource allocation, ghost workers in corruption commission, digitalization of healthcare
Nigeria public hospitals processes
Bribery for shorter wait times, conflicts of interest in Strong ethical guidelines for healthcare professional
pharmaceutical pricing, overservicing for financial independent drug price evaluation body, public acce
Norway gain healthcare expenditure data
Bribery for admission to public hospitals, illegal sale Public-private partnerships, community-based health
of prescription drugs, lack of accountability in rural committees, mobile medical units to reach underserv
Pakistan healthcare areas

Ghost patients, fraudulent procurement practices, Stricter procurement regulations, strengthened anti-
Peru counterfeit drug trade corruption agencies, whistleblower protection
Bribery for faster access to specialists, nepotism in Independent anti-corruption commission, electronic
hospital management, fraudulent billing for medical records systems, increased public oversight
Poland procedures healthcare institutions
Bribery for shorter wait times, conflicts of interest in Independent ombudsman system, transparency in
pharmaceutical contracts, nepotism in medical healthcare budgets, mandatory ethics training for
Portugal appointments healthcare professionals
Republic of Bribery, influence peddling, overprescription, Whistleblower protection, transparent pricing, ethica
Korea nepotism guidelines, awareness campaigns
Bribery, ghost patients, embezzlement, fake Anti-corruption task forces, digitalization, healthcare
Romania prescriptions inspectorate, reporting platforms
Bribery, lack of transparency, poor medicine quality, Anti-corruption legislation, public-private partnershi
Russia nepotism financial management, community monitoring
Robust anti-corruption laws, independent procureme
Slovakia Bribery, procurement conflicts, overservicing agency, spending data monitoring, public access
Ombudsman system, budget transparency, mandator
Spain Bribery, pricing influence, nepotism ethics training
Strong ethical guidelines, drug price evaluation body
Sweden Bribery, research funding conflicts, overservicing expenditure data access
Awareness campaigns, conflict of interest regulation
Switzerland Bribery, opaque pricing, medical school nepotism independent price evaluation
Public-private partnerships, stronger pharmaceutical
Turkey Bribery, overprescription, fake prescriptions regulations, pharmacy monitoring

Lack of transparency, procurement influence, Digitalization, healthcare inspectorate, pharmaceutic


UAE nepotism transparency reports
Community health insurance, anti-corruption commi
Uganda Bribery, lack of transparency, ghost workers digitalization
Healthcare inspectorate, pharmaceutical transparenc
UK Bribery, pricing influence, overservicing reports, whistleblower protection
Public-private partnerships, community health
Ukraine Bribery, drug sales, rural healthcare accountability committees, mobile medical units

Fraudulent billing, research funding conflicts, Strong anti-corruption legislation, healthcare inspect
USA pharmaceutical marketing influence data monitoring, whistleblower programs
Community health insurance, anti-corruption commi
Zambia Bribery, lack of transparency, ghost workers digitalization
Public-private partnerships, stronger pharmaceutical
Zimbabwe Bribery, overprescription, fake prescriptions regulations, pharmacy monitoring

You might also like